ASX:GMVG Medical Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding G Medical Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Compare Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume396,612 shsAverage VolumeN/AMarket Capitalization$31.86 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsInsider TradesHeadlines G Medical Innovations Holdings Ltd operates as a mobile health and e-health company. It develops and markets clinical and consumer medical-grade health monitoring solutions. The company develops Medical Smartphone Case, a solution that turns a phone into a mobile medical monitoring device; and G Medical Patch, a solution that provides continuous and real-time monitoring of a range of vital signs and biometrics. G Medical Innovations Holdings Ltd was founded in 2014 and is based in George Town, Cayman Islands.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for G Medical. Previous Next 2.4 Community Rank Outperform VotesG Medical has received 20 “outperform” votes. (Add your “outperform” vote.)Underperform VotesG Medical has received 22 “underperform” votes. (Add your “underperform” vote.)Community SentimentG Medical has received 52.38% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about G Medical and other stocks. Vote “Outperform” if you believe GMV will outperform the S&P 500 over the long term. Vote “Underperform” if you believe GMV will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldG Medical does not currently pay a dividend.Dividend GrowthG Medical does not have a long track record of dividend growth. Previous Next 3.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, G Medical insiders have bought 123.17% more of their company's stock than they have sold. Specifically, they have bought A$7,467,145.00 in company stock and sold A$3,345,875.00 in company stock. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of G Medical is -1.79, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of G Medical is -1.79, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.08 out of 5 stars Industry, Sector and Symbol Stock Exchange ASX Industry Medical Instruments & Supplies Sub-IndustryN/A SectorMedical Current SymbolASX:GMV Previous Symbol CUSIPN/A CIKN/A Webgmedinnovations.com Phone345-749-2000Debt Debt-to-Equity RatioN/A Current Ratio0.14 Quick Ratio0.06Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$5.53 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow19.29 Book ValueA($0.03) per share Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares664,664,000Market Cap$31.86 million Next Earnings DateN/A OptionableNot Optionable Receive GMV News and Ratings via Email Sign-up to receive the latest news and ratings for GMV and its competitors with MarketBeat's FREE daily newsletter. G Medical (ASX:GMV) Frequently Asked Questions Has G Medical been receiving favorable news coverage? Press coverage about GMV stock has been trending extremely negative recently, InfoTrie Sentiment Analysis reports. The research group scores the sentiment of media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. G Medical earned a media sentiment score of -4.6 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near term. View the latest news aboutG Medical. Who are some of G Medical's key competitors? Some companies that are related to G Medical include Omega Diagnostics Group (ODX), SDI (SDI), Milestone Scientific (MLSS), Daxor (DXR), Daxor (DXR), IsoRay (ISR), IsoRay (ISR), TSO3 (TOS), Impression Healthcare (IHL), TransEnterix (TRXC), Relevium Technologies (RLV), Akers Biosciences (AKR), Vigil Health Solutions (VGL), Ambu A/S (AMBBY) and Ansell (ANSLF). View all competitors. Who are G Medical's key executives? G Medical's management team includes the following people: Dr. Yacov Geva, Pres, CEO & Exec. Director (Age 69)Mr. Rafi Heumann, Pres & COO (Age 49)Mr. Kobi Ben-Efraim, Chief Financial Officer (Age 62)Mr. Nir Geva, Chief Technology Officer (Age 45)Mr. Oded Shahar, Sr. Investment Banker and Sr. VP of Merger & Acquisition (Age 58) What is G Medical's stock symbol? G Medical trades on the ASX under the ticker symbol "GMV." How big of a company is G Medical? G Medical has a market capitalization of $0.00 and generates $5.53 million in revenue each year. What is G Medical's official website? The official website for G Medical is gmedinnovations.com. How can I contact G Medical? The company can be reached via phone at 345-749-2000. This page was last updated on 6/3/2020 by MarketBeat.com Staff
